Exponent, Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2016 Q2, but the supplied filing is for the quarter and six months ended June 30, 2017, compared with periods ended July 1, 2016. This summary covers the filing provided.
Business context and reporting period
Exponent is an engineering and scientific consulting firm. Its two reportable segments are Engineering and Other Scientific, and Environmental and Health. The unaudited filing covers the second quarter and first six months of fiscal 2017.
Financial performance and liquidity
Amounts below are in millions except per-share data. Q2 and six-month comparisons are against the corresponding 2016 periods.
| Metric | Q2 2017 | Q2 2016 | First half 2017 | First half 2016 |
|---|---|---|---|---|
| Revenue | $87.84 | $77.30 | $171.96 | $160.45 |
| Revenue before reimbursements | $84.12 | $73.33 | $164.59 | $152.28 |
| Operating income | $20.32 | $14.93 | $34.95 | $31.37 |
| Net income | $13.79 | $10.45 | $30.37 | $25.80 |
| Diluted EPS | $0.51 | $0.38 | $1.13 | $0.95 |
| Operating cash flow | Not stated quarterly | Not stated quarterly | $17.19 | $14.55 |
- Q2 revenue rose 13.6%; revenue before reimbursements rose 14.7%. Net income increased 32%, and diluted EPS increased from $0.38 to $0.51. First-half revenue rose 7.2% and net income rose 17.7%.
- Management reported Q2 EBITDA margin of 28.2% of revenue before reimbursements, up from 24.6%; first-half margin was 25.8%, versus 24.3%. These are non-GAAP measures.
- At June 30, cash and cash equivalents were $90.2 million and short-term investments were $71.8 million, totaling $162.0 million, down from $173.7 million at December 30, 2016. Current assets were $278.7 million and current liabilities $68.1 million.
- Six-month investing cash outflow was $15.5 million, primarily reflecting purchases of short-term investments; financing cash outflow was $26.9 million, including dividends, share repurchases, and payroll taxes on restricted stock units.
- The balance sheet presents no debt line item. Total liabilities were $120.3 million and stockholders’ equity was $289.4 million.
Material changes and management commentary
- Q2 growth reflected stronger demand across both segments. Engineering and Other Scientific revenue grew 14.5%; Environmental and Health revenue grew 10.6%. First-half growth was 8.5% and 2.4%, respectively.
- Q2 billable hours increased 14% and utilization improved to 77% from 69%. Technical full-time equivalent employees increased to 774 from 765. Management attributed improved profitability to utilization, headcount alignment, and a large consumer-products project.
- That consumer-products project contributed approximately 5% of Q2 net revenue. Management noted that the year-over-year comparison also benefited from unusually soft results in Q2 2016.
- Q2 compensation expense rose 9.6%, while general and administrative expense rose 20.4%, including higher travel and meals associated with a firm-wide managers’ meeting. First-half G&A increased 20.3%, also reflecting anniversary-related marketing and higher legal expense.
- The company declared a $0.21-per-share dividend for Q2 and announced another $0.21 dividend payable September 22, 2017, subject to the stated record date. It repurchased $7.0 million of shares during the first half and had $50.3 million of repurchase authorization remaining at June 30.
Outlook, risks, contingencies, and unusual items
- No quantified revenue or earnings guidance is provided. Management expects to selectively recruit, invest in infrastructure, and continue dividends and may use cash for repurchases or complementary acquisitions. It expects existing liquidity to cover at least the next 12 months.
- Demand risks include economic and industry conditions, project timing, competition and pricing, limited backlog visibility, and the ability to attract and retain key employees. Management also cites regulation, tort reform, and claims exposure.
- One customer represented 12% of both Q2 and first-half revenue and 12% of receivables at June 30. No customer exceeded 10% of revenue in the comparable 2016 periods.
- The company entered conditional agreements to buy 2.9 acres in Natick, Massachusetts, for $5.2 million, with plans for office and laboratory facilities. It may terminate if feasibility, environmental, or approval conditions are unsatisfactory.
- Management said ordinary-course legal matters are not expected to have a material adverse effect, while noting litigation outcomes are uncertain. The filing reports no material legal proceedings.
- Foreign-currency exposure includes operations in pounds, euros, and yuan; the company does not hedge with foreign-exchange contracts. It estimated that a 10% move in local currency would cause a $190,000 gain or loss on specified nonfunctional-currency net assets.
- Deferred-compensation investment gains increased other income but were substantially offset by compensation expense. The company expects adoption of the new revenue standard in fiscal 2018 to have no material impact; the new lease standard is expected to materially increase reported assets and liabilities.
Important facts for investors to verify
- Confirm the intended reporting year: the supplied document is Q2 2017, not Q2 2016.
- Assess whether the unusually strong Q2 utilization and the large project are repeatable, and whether the softer prior-year comparison inflated growth rates.
- Monitor customer concentration, receivable collections, and the effect of project timing on operating cash flow.
- Review the terms and contingencies of the Massachusetts land agreements and the company’s planned capital commitments.
- Track share repurchases, dividends, compensation costs, currency exposure, and the balance-sheet effects of lease-standard adoption.